Skip to main content
. 2016 Aug 17;7(38):61273–61283. doi: 10.18632/oncotarget.11341

Figure 6. Schematic diagram illustrating the proposed ADAMTS6-mediated inhibition of the ERK1/2 signaling pathway and its role in BC cell migration, invasion, and tumorigenesis.

Figure 6